Skip to main content

Advertisement

SpringerLink
Log in

Anaemia in the Elderly IBD Patient

  • Geriatrics (S Katz, Section Editor)
  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Opinion statement

Anaemia is a common multifactorial extraintestinal manifestation in IBD patients. Moreover, anaemia represents an important health problem among the elderly population and has a significant impact on healthcare utilisation and costs. Data on the prevalence, diagnosis and management of anaemia in elderly IBD patients are scarce, since clinical trials have largely excluded this population. In this review, we reconsider anaemia in older IBD patients in the light of new diagnostic and therapeutic tools.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ACD:

Anaemia of chronic disease

CD:

Crohn’s disease

CHr:

Reticulocyte haemoglobin content

ESA:

Erythropoiesis-stimulating agent

Hb:

Haemoglobin

%HYPO:

Hypochromic red cells

IBD:

Inflammatory bowel disease

ID:

Iron deficiency

IDA:

Iron deficiency anaemia

RES:

Reticuloendothelial system

sTfR:

Soluble transferrin receptors

TfS:

Transferrin saturation

TIBC:

Total iron binding capacity

UC:

Ulcerative colitis

ZPP:

Zinc protoporphyrin

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Dignass AU et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohn's Colitis. 2015;9:211–22. This paper highlights the current standards in the diagnosis and management of anaemia in IBD patients and is the result of a European consensus process under the guidance of the European Crohn's and Colitis Organisation (ECCO).

    Google Scholar 

  2. Stein J, Hartmann F, Dignass AU. Diagnosis and management of iron deficiency anemia in patients with IBD. Nature reviews. Gastroenterol Hepatol. 2010;7:599–610.

    CAS  Google Scholar 

  3. Ershler WB, Chen K, Reyes EB, Dubois R. Economic burden of patients with anemia in selected diseases. Value Health. 2005;8:629–38.

    PubMed  Google Scholar 

  4. Gasche C. Anemia in IBD: the overlooked villain. Inflamm Bowel Dis. 2000;6:142–50. discussion 151.

    CAS  PubMed  Google Scholar 

  5. Gomollon F, Gisbert JP. Current management of iron deficiency anemia in inflammatory bowel diseases: a practical guide. Drugs. 2013;73:1761–70. This paper summarizes the current standards in the management of anaemia in IBD patients in a very practical approach.

    CAS  PubMed  Google Scholar 

  6. Gomollon F, Gisbert JP. Anemia and inflammatory bowel diseases. World J Gastroenterol. 2009;15:4659–65.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Ruel J, Ruane D, Mehandru S, Gower-Rousseau C, Colombel JF. IBD across the age spectrum: is it the same disease? Nat Rev Gastroenterol Hepatol. 2014;11:88–98. This paper is an up-to-date review about IBD at different ages and also provides useful aspects of IBD in the elderly.

    PubMed  Google Scholar 

  8. Ha CY, Katz S. Clinical implications of ageing for the management of IBD. Nat Rev Gastroenterol Hepatol. 2014;11:128–38. This paper is an up-to-date review about IBD at different ages and also provides useful aspects of IBD in the elderly.

    CAS  PubMed  Google Scholar 

  9. Juneja M et al. Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity. Dig Dis Sci. 2012;57:2408–15.

    PubMed  Google Scholar 

  10. Reinisch W et al. A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED). Am J Gastroenterol. 2013;108:1877–88.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. WHO, UNICEF, UNU. Iron deficiency anemia: assessment, prevention and control. Report of a joint WHO/UNICEF/UNU consultation. Geneva: World Health Organization; 1998.

    Google Scholar 

  12. Patel D, Kalkat P, Baisch D, Zipser R. Celiac disease in the elderly. Gerontology. 2005;51:213–4.

    PubMed  Google Scholar 

  13. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104:2263–8.

    CAS  PubMed  Google Scholar 

  14. Hindryckx P et al. Belgian recommendations for the management of anemia in patients with inflammatory bowel disease. Acta Gastro-enterol Belg. 2014;77:333–44.

    CAS  Google Scholar 

  15. Wilhelm-Leen ER, Hall YN, Deboer IH, Chertow GM. Vitamin D deficiency and frailty in older Americans. J Intern Med. 2010;268:171–80.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Filmann N et al. Prevalence of anemia in inflammatory bowel diseases in European countries: a systematic review and individual patient data meta-analysis. Inflamm Bowel Dis. 2014;20:936–45. This paper provides a recent analysis of the frequency of anaemia in IBD patients.

    PubMed  Google Scholar 

  17. Tal S, Shavit Y, Stern F, Malnick S. Association between vitamin B12 levels and mortality in hospitalized older adults. J Am Geriatr Soc. 2010;58:523–6.

    PubMed  Google Scholar 

  18. Tal S, Guller V, Shavit Y, Stern F, Malnick S. Mortality predictors in hospitalized elderly patients. QJM. 2011;104:933–8.

    CAS  PubMed  Google Scholar 

  19. Gassull MA, Cabre E. Nutrition in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care. 2001;4:561–9.

    CAS  PubMed  Google Scholar 

  20. Gasche C et al. Diagnosis and treatment of iron deficiency and anaemia in inflammatory bowel diseases. Consensus of the Austrian IBD Working Party. Z Gastroenterol. 2011;49:627–32.

    CAS  PubMed  Google Scholar 

  21. Tay HS, Soiza RL. Systematic review and meta-analysis: what is the evidence for oral iron supplementation in treating anaemia in elderly people? Drugs Aging. 2015;32:149–58.

    CAS  PubMed  Google Scholar 

  22. Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem. 1998;44:45–51.

    CAS  PubMed  Google Scholar 

  23. Stein J, Dignass AU. Management of iron deficiency anemia in inflammatory bowel disease—a practical approach. Ann Gastroenterol. 2013;26:104–13.

    PubMed  PubMed Central  Google Scholar 

  24. Dagg JH, Goldberg A, Lochhead A. Value of erythrocyte protoporphyrin in the diagnosis of latent iron deficiency (sideropenia). Br J Haematol. 1966;12:326–30.

    CAS  PubMed  Google Scholar 

  25. Veit LE, Maranda L, Fong J, Nwosu BU. The vitamin D status in inflammatory bowel disease. PLoS One. 2014;9, e101583.

    PubMed  PubMed Central  Google Scholar 

  26. Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372:1832–43 This paper is an up-to-date review about iron-deficiency anaemia summarizing the current knowledge of this topic.

    PubMed  Google Scholar 

  27. Sim JJ et al. Vitamin D deficiency and anemia: a cross-sectional study. Ann Hematol. 2010;89:447–52.

    CAS  PubMed  Google Scholar 

  28. Lac PT et al. The effects of changing vitamin D levels on anemia in chronic kidney disease patients: a retrospective cohort review. Clin Nephrol. 2010;74:25–32.

    CAS  PubMed  Google Scholar 

  29. Bacchetta J et al. Suppression of iron-regulatory hepcidin by vitamin D. J Am Soc Nephrol. 2014;25:564–72.

    CAS  PubMed  Google Scholar 

  30. Gasche C et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007;13:1545–53.

    PubMed  Google Scholar 

  31. Remacha AF et al. Combined cobalamin and iron deficiency anemia: a diagnostic approach using a model based on age and homocysteine assessment. Ann Hematol. 2013;92:527–31.

    CAS  PubMed  Google Scholar 

  32. Fairweather-Tait SJ, Wawer AA, Gillings R, Jennings A, Myint PK. Iron status in the elderly. Mech Ageing Dev. 2014;136–137:22–8.

    PubMed  PubMed Central  Google Scholar 

  33. Casale G, Bonora C, Migliavacca A, Zurita IE, de Nicola P. Serum ferritin and ageing. Age Ageing. 1981;10:119–22.

    CAS  PubMed  Google Scholar 

  34. Joosten E, Hiele M, Ghoos Y, Pelemans W, Boogaerts MA. Diagnosis of iron-deficiency anemia in a hospitalized geriatric population. AmJ Med. 1991;90:653–4.

    CAS  Google Scholar 

  35. Price EA, Mehra R, Holmes TH, Schrier SL. Anemia in older persons: etiology and evaluation. Blood Cells Mol Dis. 2011;46:159–65.

    CAS  PubMed  Google Scholar 

  36. Heimpel H, Diem H, Nebe T. Die Bestimmung der Retikulozytenzahl: Eine alte Methode gewinnt neue Bedeutung [Counting reticulocytes: new importance of an old method]. Med Klin (Munich). 2010;105:538–43.

    Google Scholar 

  37. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997;89:1052–7.

    CAS  PubMed  Google Scholar 

  38. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor, ferritin and TfR-F index in identification of latent iron deficiency. Eur J Haematol. 1998;60:135–7.

    CAS  PubMed  Google Scholar 

  39. Koulaouzidis A, Said E, Cottier R, Saeed AA. Soluble transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review. J Gastrointestinal and liver diseases : JGLD. 2009;18:345–52.

    Google Scholar 

  40. Thomas C, Thomas L. Anemia of chronic disease: pathophysiology and laboratory diagnosis. Lab Hematol. 2005;11:14–23.

    CAS  PubMed  Google Scholar 

  41. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem. 2002;48:1066–76.

    CAS  PubMed  Google Scholar 

  42. van Santen S et al. Hematologic parameters predicting a response to oral iron therapy in chronic inflammation. Haematologica. 2014;99:e171–3.

    PubMed  PubMed Central  Google Scholar 

  43. Hastka J, Lasserre JJ, Schwarzbeck A, Strauch M, Hehlmann R. Zinc protoporphyrin in anemia of chronic disorders. Blood. 1993;81:1200–4.

    CAS  PubMed  Google Scholar 

  44. Hastka J, Lasserre JJ, Schwarzbeck A, Hehlmann R. Central role of zinc protoporphyrin in staging iron deficiency. Clin Chem. 1994;40:768–73.

    CAS  PubMed  Google Scholar 

  45. Goddard AF, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. Br Soc Gastroenterol Gut. 2000;46(Suppl 3–4):IV1–5.

    Google Scholar 

  46. Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. 2015;10, e0117383.

    PubMed  PubMed Central  Google Scholar 

  47. Zimmermann MB et al. The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d'Ivoire. Am jJ Clinical nutrition. 2010;92:1406–15.

    CAS  Google Scholar 

  48. Kortman GA, Raffatellu M, Swinkels DW, Tjalsma H. Nutritional iron turned inside out: intestinal stress from a gut microbial perspective. FEMS Microbiol Rev. 2014;38:1202–34.

    CAS  PubMed  Google Scholar 

  49. Busti F, Campostrini N, Martinelli N, Girelli D. Iron deficiency in the elderly population, revisited in the hepcidin era. Front Pharmacol. 2014;5:83.

    PubMed  PubMed Central  Google Scholar 

  50. Avni T, Bieber A, Steinmetz T, Leibovici L, Gafter-Gvili A. Treatment of anemia in inflammatory bowel disease—systematic review and meta-analysis. PLoS One. 2013;8, e75540.

    PubMed  PubMed Central  Google Scholar 

  51. Avni T et al. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc. 2015;90:12–23.

    PubMed  Google Scholar 

  52. Geisser P, Baer M, Schaub E. Structure/histotoxicity relationship of parenteral iron preparations. Arzneimittelforschung. 1992;42:1439–52.

    CAS  PubMed  Google Scholar 

  53. Rohrig G et al. Efficacy and tolerability of ferric carboxymaltose in geriatric patients with anemia. Data from three non-interventional studies. MMW Fortschritte der Medizin. 2014;156 Suppl 2:48–53.

    PubMed  Google Scholar 

  54. Dali-Youcef N, Andres E. An update on cobalamin deficiency in adults. QJM. 2009;102:17–28.

    CAS  PubMed  Google Scholar 

  55. Devalia V, Hamilton MS, Molloy AM, British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166:496–513.

    CAS  PubMed  Google Scholar 

  56. Hvas AM, Nexo E. Diagnosis and treatment of vitamin B12 deficiency—an update. Haematologica. 2006;91:1506–12.

    CAS  PubMed  Google Scholar 

  57. Hlavaty T, Krajcovicova A, Payer J. Vitamin D therapy in inflammatory bowel diseases: who, in what form, and how much? J Crohns Colitis. 2015;9:198–209.

    PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Jürgen Stein has received consultancy fees from Abbvie, Fresenius-Kabi, Immundiagnostik, MSD, Pharmacosmos, Takeda, and Vifor. Dr. Stein has also received payment for lectures from Abbvie, Falk Foundation, Ferring, Immundiagnostik, MSD, Pharmacosmos, Takeda, Thermofischer and Vifor. Additionally, Dr. Stein has received payment for manuscript preparation from Abbvie, Falk Foundation and MSD.

Axel U. Dignass has received consultancy fees from Abbott, MSD, Ferring, UCB, Otsuka, Roche/Genentech, Takeda, Pharmacosmos, Holystone Biotech and Falk Foundation. Dr. Dignass has also received grants from Institut für Gemeinwohl and Stiftung Leben mit Krebs as well as payment for lectures including service on speakers bureaus from Falk Foundation, Ferring, MSD, Abbott, Otsuka, Vifor, Stiftung Leben mit Krebs, Kompetenznetz CED, Takeda and Pharmacosmos. Additionally, Dr. Dignass has received payment for manuscript preparation from Falk Foundation and payment for development of education presentations from Abbott, Pharmacosmos, Falk Foundation and Ferring.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Gastroenterology and Clinical Nutrition, DGD Clinics Frankfurt-Sachsenhausen, Teaching Hospital of the Goethe University Frankfurt, Schulstrasse 31, 60594, Frankfurt/Main, Germany

    Jürgen Stein MD, PhD, FEBG

  2. Department of Medicine I, Agaplesion Markus Hospital, 60431, Frankfurt/Main, Germany

    Axel U. Dignass MD, PhD, FEBG

  3. Crohn Colitis Clinical Research Centre Rhein-Main, 60594, Frankfurt/Main, Germany

    Jürgen Stein MD, PhD, FEBG & Axel U. Dignass MD, PhD, FEBG

Authors
  1. Jürgen Stein MD, PhD, FEBG
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Axel U. Dignass MD, PhD, FEBG
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jürgen Stein MD, PhD, FEBG.

Additional information

This article is part of the Topical Collection on Geriatrics

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stein, J., Dignass, A.U. Anaemia in the Elderly IBD Patient. Curr Treat Options Gastro 13, 308–318 (2015). https://doi.org/10.1007/s11938-015-0062-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-015-0062-y

Keywords

Search

Navigation